This report emphasizes the precise topographic distribution of cerebral met
abolic impairment in corticobasal degeneration (CBD) and the pathophysiolog
ical differences between CBD and progressive supranuclear palsy (PSP). Stat
istical parametric mapping (SPM96) analysis of (18)FDG positron emission to
mography (PET) data was performed in 22 patients with CBD compared with 46
healthy subjects (HS) and 21 patients with PSP who were studied at rest. A
statistical threshold of p <0.001 was fixed, further corrected for multiple
or independent comparisons (p <0.05). In comparison with HS, the metabolic
impairment in CBD was asymmetrically distributed in the putamen, thalamus,
precentral (Brodmann's area, BA 4), lateral premotor (BA 6/44) and supplem
entary motor areas (SMA, BA 6), dorsolateral prefrontal (8/9/46) cortex, an
d the anterior part of the inferior parietal lobe (BA 40) including the int
raparietal sulcus (BA 7/40). A similar hypometabolic pattern was observed f
or most individual analyses. When PSP was compared with CBD, metabolic impa
irment predominated in the midbrain, anterior cingulate (BA 24/32), and orb
itofrontal regions (BA 10). The reverse contrast showed more posterior invo
lvement in CBD (BA 6 and 5/7/40) including SMA. Our data suggest that multi
ple components of neural networks related to both movement execution and pr
oduction of skilled movements are functionally disturbed in CBD compared wi
th both HS and PSP.